Americas vs Bangladesh: Proportion of the target population who received a 3rd dose of
Americas
79.0%
in 2024
Bangladesh
97.0%
in 2024
Americas rank
14th
Bangladesh rank
11th
Proportion of the target population who received a 3rd dose of over time
- Americas
- Bangladesh
How they compare
Bangladesh currently reports 97.0% against 79.0% in Americas, a difference of 18.0%.
That makes Bangladesh's figure about 1.2 times Americas's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Americas ahead.
Americas ranks 14th and Bangladesh ranks 11th of 37 groups.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas | Bangladesh | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.4% | 88.2% | 5.8% | Bangladesh |
| 2020s | 76.4% | 97.4% | 21.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Americas or Bangladesh?
- Bangladesh, at 97.0% against 79.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Americas and Bangladesh?
- 18.0%, with Bangladesh ahead.
- How many years of comparable data are there for Americas and Bangladesh?
- 10 years are reported by both, from 2015 to 2024.
- How do Americas and Bangladesh rank globally for proportion of the target population who received a 3rd dose of?
- Americas ranks 14th and Bangladesh ranks 11th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.